Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: Comparison with homologous blood transfusion (running title: Postoperative blood loss in CABG)

Iranian Heart Journal

Volumn 13, Issue 2, 2012, Pages 24-34

  Aghdaii, Nahid ^a   Kabiri, Majid ^b   Yazdanian, Forouzan ^a   Ghaffarinejad, Mohammad Hasan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autologous blood transfusion; Cell saver; Coronary artery bypass grafting

Indexed keywords

HEPARIN;

ADULT; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SALVAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; MALE; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84869804087     PISSN: 17357306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20:230-241.
2. Shander A, Moskowitz D, Rijhwani TS. The safety and efficacy of "bloodless" cardiac surgery. Seminar Cardiothorac Vasc Anesth 2005;9:53-63.
3. Herbertson M: Recombinant activated factor VII in cardiac surgery. Blood Coagula Fibrinolysis 2004;15:31-32.
4. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest 1999;115:1598-1603.
5. Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, et al. Effect of peri-operative red blood cell transfusion on 30-day and 1- year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;27:592-8.
6. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, Herruzo-Avilés A, Camacho-Laraña P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-1468.
7. Ranucci M. Allogeneic blood transfusions and infections after cardiac surgery. American Heart J 2007;153:21
8. Vamvakas EC, Carven JH. Allogeneic blood transfusion and postoperative duration of mechanical ventilation: Effects of red cell supernatant, platelet supernatant, plasma components and total transfused fluid. Vox Sang 2002;82:141-149.
9. Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, et al. Risk factors for renal dysfunction after coronary surgery: The role of cardiopulmonary bypass technique. Perfusion 1994;9:319-326.
10. Song Y, Li R, Gu XH, Gong XJ, Zhang G, Wu SM, et al. Effects of blood washing and autotransfusion during cardiopulmonary bypass on erythrocyte immune and kidney function. Zhonghua Yi Xue Za Zhi. 2006 Aug 29;86:2293-6.
11. Maitra G, Ahmed A, Rudra A, Wankhede R, Sengupta S, Das T. Renal dysfunction after off-pump coronary artery bypass surgery- risk factors and preventive strategies. Indian J Anaesth. 2009;53:401-7
12. Koch CG, Khandwala F, Li L, Estafanous FG, Loop FD, Blackstone EH. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 2006;82:13-20.
13. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006;81:1650-1657.
14. Stainsby D, Jones H, Asher D, Atterbury C, Boncinelli A, Brant L, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006;20:273-82.
15. H.M. van Straten, M. W.A. Bekker, M. A. Soliman Hamad, A. A.J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up.Interactive CardioVascular and Thoracic Surgery 2010;10:37-42.
16. Rawn JD. Blood transfusion in cardiac surgery. A silent epidemic revisited. Circulation 2007;116:2523-2524.
17. Roche JK, Stengle JM. Open-heart surgery and the demand for blood. JAMA. 1973; 1225:1516-21.
18. McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. Br Med J 2002;324:1299
19. Niranjan G, Asimakopoulos G, Karagounis A, Cocerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on-versusoff- cardiopulmonary bypass: a randomized trial. Eur J Cardiothorac Surg 2006;30:271-277
20. Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple-Hay MJ. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial. Ann Thorac Surg 2004;77:1553-1559.
21. Marx A, Lüpke U, Tessmann R, Lindhoff-Last E. Removal of lepirudin used as an anticoagulant in mechanical autotransfusion with Cell-Saver. Anaesthesist. 2001 Jan;50(1):26-31.
22. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59: 62-7
23. Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, et al. Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985;11:281-92
24. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993;82:107-17.
25. Diprose P, Herbertson MJ, O'Shaughnessy D, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo- controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth 2005;94:271-8.
26. Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009;109:320-30.
27. Paravicini D., Wasylewski A.H., Rassat J., Thys J. Red blood cell survival and morphology during and after intra-operative auto transfusion. Acta Anaesthisiol Belg 1984;35:43-49.
28. Gu YJ, Vermeijden WJ, de Vries AJ, Hagenaars JA, Graaff R, van Oeveren W. Influence of mechanical cell salvage on red blood cell aggregation, deformability,and2,3-diphosphoglycerate in patients undergoing cardiac surgery with cardiopulmonary bypass. Ann Thorac Surg. 2008;86:1570-5.
29. Vorweg M, Muckel G, Knüttgen D, Schindler A, Doehn M. Heparin-induced coagulation disturbance from mechanical autotransfusion. Anaesthesist. 1998 Dec;47:979-81.
30. Reents W., Babin-Ebell J., Misoph M.R., Schwarzkopf A., Elert O. Influence of different autotransfusion devices on the quality of salvaged blood. Ann Thorac Surg 1999;68:58-62
31. Boldt J, Zickmann B, Herold C, Scholz S, Dapper F, Hempelmann G. Heparin management during cardiac surgery with respect to various blood-conservation techniques. Surgery. 1992;111:260-5.
32. Klein AA, Nashef SA, Sharples L, Bottrill F, Dyer M, Armstrong J, et al. A randomized Controlled Trial of Cell Salvage in Routine Cardiac Surgery. - Anesth Analg 2008;107:1487-1495.